Dynavax and Clover Biopharmaceuticals Announce Research Collaboration to Evaluate Coronavirus (COVID-19) Vaccine Candidate with CpG 1018 Adjuvant Mar 24, 2020 Life Science
Healthcare Roundup – Gilead’s remdesivir wins orphan drug status for coronavirus, New York launches use of malaria drug to treat Covid-19 Mar 23, 2020 Life Science
Amazon will deliver and pick up at-home test kits provided by new coronavirus program in Seattle Mar 23, 2020 Life Science
Ascentage Pharma Announces First Patient Dosed in the Global Phase Ib/II Clinical Study of Bcl-2 Inhibitor APG-2575 in the United States Mar 23, 2020 Life Science
Chinese Center for Drug Evaluation (CDE) Cleared Taletrectinib IND and Issued Clinical Trial Authorizations for Two Phase 2 Clinical Trials in China Mar 23, 2020 Life Science
Healthcare Roundup – U.S. coronavirus cases top 15K as more testing becomes available, 3M beefs up production of respirators to meet coronavirus demand Mar 21, 2020 Life Science
Sorrento Develops STI-4398 (Covidtrap™ Protein) For Potential Prevention And Treatment Of SARS-COV-2 Coronavirus Disease (COVID-19) Mar 20, 2020 Life Science
WHO officials say at least 20 coronavirus vaccines are in development in global race for cure Mar 20, 2020 Life Science
Healthcare Roundup – Teva to donate 6M doses of malaria drug for coronavirus use, Italy now world’s #1 Covid-19 hotspot Mar 20, 2020 Life Science
Ovation Science Ramps-Up Its Manufacturing of DermSafe as Health Canada Takes Action to Increase the Supply of Hand Sanitizers to Manage the Spread of Coronavirus COVID-19 Mar 19, 2020 Life Science
Healthcare Roundup – Trump invokes Defense Production Act in response to virus, Gilead’s Covid-19 drug may get quick FDA approval Mar 18, 2020 Technology
China’s CanSino pushes coronavirus vaccine into clinical testing as Moderna kicks off trial Mar 18, 2020 Life Science
Healthcare Roundup – AbbVie and Allergan ink agreement, Qiagen to ramp up production of RNA extraction kits for coronavirus tests Mar 18, 2020 Life Science
InxMed Announces Dosing of First Patient in a Phase Ib Trial of IN10018 as Monotherapy and Combination Therapy in Patients with Uveal Melanoma and NRAS mutant Metastatic Melanoma in the United States Mar 17, 2020 Life Science